Dushyant Goyal
About Dushyant Goyal
Dushyant Goyal is the Director HR - US Commercial (Immunology, Cardiovascular, Established Brands, Puerto Rico) at Bristol Myers Squibb, with extensive experience in HR leadership roles at Novartis and Ernst & Young.
Current Position at Bristol Myers Squibb
Dushyant Goyal is currently serving as the Director HR - US Commercial (Immunology, Cardiovascular, Established Brands, Puerto Rico) at Bristol Myers Squibb. In this role, he provides HR leadership for a $10 billion business with approximately 1,500 employees across multiple franchises in the US.
Previous Experience at Novartis Institutes for BioMedical Research
From 2018 to 2022, Dushyant Goyal worked at Novartis Institutes for BioMedical Research (NIBR) as Director HR in the Greater New York City Area. During his tenure, he led several significant reorganizations and rapid scale-ups at both country and global levels, showcasing his ability to handle complex HR challenges.
Global Operational Excellence Lead at Novartis International AG
Between 2016 and 2018, Dushyant Goyal served as the Global Operational Excellence Lead - Group Talent Management & OD at Novartis International AG in Basel Area, Switzerland. In this capacity, he leveraged his expertise in HR partnering, specialist HR, and project leadership.
HR Leadership Roles in Southern Africa and AMAC at Novartis Pharmaceuticals
From 2014 to 2016, Goyal was the Head HR Southern Africa Country Group / Head Compensation & Benefits SSA at Novartis Pharmaceuticals in Johannesburg Area, South Africa. Prior to that, he held the position of HR Lead - Pharma Region AMAC, Sales Incentive Transformation in Basel Area, Switzerland for 9 months in 2013-2014.
Educational Background in Human Resources and Engineering
Dushyant Goyal holds a Master of Business Administration (M.B.A.) in Human Resources Management/Personnel Administration from XLRI Jamshedpur, where he studied from 2006 to 2008. He also has a Bachelor of Engineering (B.E.) in Computer Science from Birla Institute of Technology, Mesra, completed between 2002 and 2006.